Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) declared a quarterly dividend on Wednesday, February 5th,Wall Street Journal reports. Stockholders of record on Friday, March 14th will be given a dividend of 0.305 per share by the medical instruments supplier on Thursday, April 3rd. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date is Friday, March 14th.
Utah Medical Products Trading Down 0.5 %
Shares of Utah Medical Products stock traded down $0.31 during mid-day trading on Friday, reaching $59.59. 2,144 shares of the stock were exchanged, compared to its average volume of 24,254. The company has a market cap of $202.13 million, a price-to-earnings ratio of 15.14 and a beta of 0.08. The firm has a 50-day simple moving average of $62.15 and a 200 day simple moving average of $65.15. Utah Medical Products has a fifty-two week low of $59.42 and a fifty-two week high of $77.33.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.92% and a return on equity of 11.07%.
Analyst Ratings Changes
Separately, StockNews.com cut shares of Utah Medical Products from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 7th.
View Our Latest Research Report on Utah Medical Products
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Articles
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
